IP Library Assignment 046696/0772
Patent Assignment
Reel/Frame 046696/0772

Security Interest

Recorded: 2018-08-24 Pages: 8
Assignor
ARALEZ PHARMACEUTICAL TRADING DAC
Executed: 2018-08-10
Assignee
DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties (23)
Nor-Seco Himbacine Derivatives Useful as Thrombin Receptor Antagonists
Patent: 6,645,987 →
Application: 09/880,222 →
Publication: US 2002/0026050
Thrombin Receptor Antagonists
Patent: 7,304,078 →
Application: 10/412,982 →
Publication: US 2003/0216437
Thrombin Receptor Antagonists
Patent: 6,894,065 →
Application: 10/457,256 →
Publication: US 2004/0006105
Thrombin Receptor Antagonists
Patent: 7,488,742 →
Application: 10/671,216 →
Publication: US 2004/0152736
Crystalline Polymorph of a Bisulfate Salt of a Thrombin Receptor Antagonist
Patent: 7,235,567 →
Application: 10/755,066 →
Publication: US 2004/0176418
Exo-Selective Synthesis of Himbacine Analogs
Patent: 7,772,276 →
Application: 11/330,521 →
Publication: US 2006/0217422
Synthesis of Himbacine Analogs
Patent: 7,541,471 →
Application: 11/330,935 →
Publication: US 2006/0173189
Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
Patent: 7,605,275 →
Application: 11/331,324 →
Publication: US 2006/0247450
Thrombin Receptor Antagonists
Patent: 7,713,999 →
Application: 11/733,635 →
Publication: US 2007/0179187
Synthesis of Diethyl{[5-(3-Fluorophenyl)-Pyridine-2YL]Methyl}Phosphonate
Patent: 7,687,631 →
Application: 11/824,245 →
Publication: US 2008/0004449
Methods of Use of Fenofibric Acid
Patent: 7,915,247 →
Application: 12/141,280 →
Methods of Use of Fenofibric Acid
Patent: 7,569,612 →
Application: 12/141,377 →
Synthesis of Himbacine Analogs
Patent: 7,626,045 →
Application: 12/428,773 →
Publication: US 2009/0203925
Methods of Use of Fenofibric Acid
Patent: 7,741,373 →
Application: 12/501,678 →
Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
Patent: 7,989,653 →
Application: 12/505,079 →
Publication: US 2009/0281321
Methods of Use of Fenofibric Acid
Patent: 7,741,374 →
Application: 12/556,644 →
Synthesis of Diethyl{[5-(3-Fluorophenyl)-Pyridine-2YL]Methyl}Phosphonate
Patent: 8,329,905 →
Application: 12/701,174 →
Publication: US 2010/0137597
Exo-Selective Synthesis of Himbacine Analogs
Patent: 8,138,180 →
Application: 12/827,000 →
Publication: US 2010/0267947
Exo- and Diastereo- Selective Synthesis of Himbacine Analogs
Patent: 8,258,319 →
Application: 13/168,029 →
Publication: US 2011/0251392
Exo-Selective Synthesis of Himbacine Analogs
Patent: 8,273,790 →
Application: 13/370,768 →
Publication: US 2012/0142914
Active Metabolite of a Thrombin Receptor Antagonist
Patent: 8,575,351 →
Application: 13/376,093 →
Publication: US 2012/0214845
Exo- and Diastereo- Selective Synthesis of Himbacine Analogs
Patent: 8,618,314 →
Application: 13/563,136 →
Publication: US 2012/0296093
Co-Crystal of the Par-1 Receptor Antagonists Vorapaxar and Asprin
Patent: 9,604,971 →
Application: 14/905,193 →
Publication: US 2016/0159779
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 1, 2009
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: AR HOLDING COMPANY, INC.
Reel/Frame 023584/0012 →
Security Agreement Jul 13, 2010
From: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
To: UBS AG, STAMFORD BRANCH
Reel/Frame 024672/0325 →
Assignment of Assignor's Interest Sep 24, 2010
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: AR HOLDING COMPANY, INC.
Reel/Frame 025039/0040 →
Assignment of Assignor's Interest Sep 27, 2010
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: AR HOLDING COMPANY, INC.
Reel/Frame 025039/0390 →
Assignment of Assignor's Interest Apr 14, 2011
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: AR HOLDING COMPANY, INC.
Reel/Frame 026125/0855 →
Release of Security Interest Aug 4, 2011
From: UBS AG, STAMFORD BRANCH, A SWISS BANKING INSTITUTION
To: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
Reel/Frame 026700/0882 →
Release of Security Interest Aug 4, 2011
From: UBS AG, STAMFORD BRANCH, A SWISS BANKING INSTITUTION
To: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
Reel/Frame 026700/0240 →
Release of Security Interest Aug 15, 2011
From: UBS AG, STAMFORD BRANCH, A SWISS BANKING INSTITUTION
To: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
Reel/Frame 026747/0703 →
Change of Name Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →
Merger Nov 30, 2012
From: AR HOLDING COMPANY, INC.
To: MPC OLDCO, INC.
Reel/Frame 029378/0850 →
Assignment of Assignor's Interest Dec 26, 2012
From: MPC OLDCO, INC.
To: MUTUAL PHARMACEUTICAL COMPANY, INC.
Reel/Frame 029526/0361 →
Assignment of Assignor's Interest May 22, 2015
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: TRIBUTE PHARMACEUTICALS INTERNATIONAL INC.
Reel/Frame 035700/0819 →
Corrective Assignment to Correct the Jurisdiction of Incorporation Previously Recorded on Reel 035700 Frame 0819. Assignor(S) Hereby Confirms the Assignment. Jun 2, 2015
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: TRIBUTE PHARMACEUTICALS INTERNATIONAL INC.
Reel/Frame 035831/0513 →
Assignment of Assignor's Interest Sep 16, 2016
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 039767/0695 →
Security Interest Sep 29, 2016
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PARTNERS, L.P.
Reel/Frame 039892/0309 →
Nunc Pro Tunc Assignment Dec 21, 2016
From: TRIBUTE PHARMACEUTICALS INTERNATIONAL INC.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 041091/0860 →
Corrective Assignment to Correct the Conveying Party Previously Recorded at Reel: 046696 Frame: 0772. Assignor(S) Hereby Confirms the Assignment. Aug 30, 2018
From: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046988/0741 →
Receiving Party/Assignee Address Change for Assignment Recorded at Reel/Frame 039767/0695 Aug 31, 2018
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 046989/0669 →
Release of Security Interest Feb 20, 2019
From: DEERFIELD MANAGEMENT COMPANY L.P.
To: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
Reel/Frame 048386/0902 →
Assignment of Assignor's Interest Apr 18, 2019
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: ATHENA BIOSCIENCE, LLC
Reel/Frame 048930/0107 →
Assignment of Assignor's Interest Sep 10, 2020
From: TOPROL ACQUISITION LLC
To: XSPIRE PHARMA, LLC
Reel/Frame 053731/0376 →
Assignment of Assignor's Interest Oct 12, 2020
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: TOPROL ACQUISITION LLC
Reel/Frame 054027/0047 →
Security Interest Oct 29, 2025
From: ATHENA BIOSCIENCE, LLC; ROSEMONT PHARMACEUTICALS LLC; PALMETTO PHARMACEUTICALS, LLC
To: GLAS TRUST CORPORATION LIMITED, AS SECURITY AGENT
Reel/Frame 072722/0333 →
Assignment of Assignor's Interest Dec 22, 2025
From: ATHENA BIOSCIENCE, LLC
To: ROSEMONT PHARMACEUTICALS LLC
Reel/Frame 073287/0566 →